KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
24,50 USD
0,00%
(0,00) 1D
1. lis, 10:21:43 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za KSPHF...
Trž. kap.
172,67 mlr.
Prosj. kol.
20,00
Količina
0,00
52-tjed. najviša
31,90 USD
52-tjed. najniža
24,50 USD
Beta
13,94
Dionice u optjecaju
46,54 mil.
Broj djelatnika
2 tis.
Trž. kap.
172,67 mlr.
Prosj. kol.
20,00
Količina
0,00
52-tjed. najviša
31,90 USD
52-tjed. najniža
24,50 USD
Beta
13,94
Dionice u optjecaju
46,54 mil.
Broj djelatnika
2 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
hr.bloombergadria.com
·
prije 2 dana
Trump slavi rekorde na Wall Streetu, ali iza burzovne euforije krije se opasna istina
Yahoo Finance
·
prije 11 minuta
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Cryptonews.net
·
prije 6 minuta
Crypto's Next Big Opportunity? Nasdaq CEO Highlights Tokenization's Billion-Dollar Potential
The Globe and Mail
·
prije 1 sat
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
Profil
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
Kissei Pharmaceutical Co Ltd – informacije
Glavni izvršni direktorMutsuo Kanzawa
Zaposlenici1,79 tis.
Osnovano9. kol 1946.
SjedišteMatsumoto, Nagano, Japan
Sektor-
Web-lokacijakissei.co.jp